Back to ANRO
MARSHALL WACE, LLP ANRO Position History
Alto Neuroscience, Inc. • Healthcare
Quarters held
16
Latest value
$21.9M
Q3 2026
Peak value
$21.9M
First seen
Q1 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2024 | $327K |
| Q4 2024 | $3.5M |
| Q1 2025 | $34K |
| Q1 2025 | $1.8M |
| Q2 2025 | $136K |
| Q2 2025 | $1.9M |
| Q3 2025 | $113K |
| Q3 2025 | $3.2M |
| Q4 2025 | $564K |
| Q4 2025 | $2.3M |
| Q4 2025 | $586K |
| Q1 2026 | $408K |
| Q1 2026 | $3.6M |
| Q2 2026 | $10K |
| Q2 2026 | $5.9M |
| Q3 2026 | $21.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $21.9M | 859.3K | — | — |
| Q2 2026 | $5.9M | 225.1K | — | — |
| Q2 2026 | $10K | 394 | — | — |
| Q1 2026 | $3.6M | 158.2K | — | — |
| Q1 2026 | $408K | 18.2K | — | — |
| Q4 2025 | $586K | 32.9K | — | — |
| Q4 2025 | $2.3M | 128.5K | — | — |
| Q4 2025 | $564K | 31.7K | — | — |
| Q3 2025 | $3.2M | 797.1K | — | — |
| Q3 2025 | $113K | 28.1K | — | — |
| Q2 2025 | $1.9M | 875.5K | — | — |
| Q2 2025 | $136K | 61.9K | — | — |
| Q1 2025 | $1.8M | 837.4K | — | — |
| Q1 2025 | $34K | 15.6K | — | — |
| Q4 2024 | $3.5M | 837.4K | — | — |
| Q1 2024 | $327K | 21.3K | — | — |
Other funds holding ANRO
$97.8M
$94.7M
$83.4M
$71.9M
$69.5M
$61.2M